Results 51 to 60 of about 27,614 (216)
ABSTRACT Invasive aspergillosis, though typically seen in immunocompromised patients, can also affect immunocompetent individuals and mimic pulmonary malignancy. This case highlights the importance of considering fungal infections in the differential diagnosis of chronic respiratory symptoms, particularly in patients with risk factors such as heavy ...
Kumail Khandwala +4 more
wiley +1 more source
Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and Treatment
Aspergillus is a mold that may lead to different clinical pictures, from allergic to invasive disease, depending on the patient’s immune status and structural lung diseases.
Alessandro Russo +3 more
doaj +1 more source
A CASE OF CHRONIC PULMONARY ASPERGILLOSIS AS THE INITIAL PRESENTATION FOR SARCOIDOSIS [PDF]
Si Yuan Khor +5 more
openalex +1 more source
ABSTRACT Disseminated Mycobacterium avium complex (MAC) infection can mimic tuberculosis (TB) in immunocompetent individuals, leading to diagnostic and therapeutic challenges. Clinicians should consider nontuberculous mycobacteria (NTM) in patients unresponsive to anti‐tubercular therapy (ATT), especially in endemic regions.
Abdulla Bin Hridoy +7 more
wiley +1 more source
Mortality Risk Factors in Hematological Patients with Pulmonary Aspergillosis at the Medical Clinic Instituto de Prevision Social - Hospital Central. Year 2016 to 2018 [PDF]
Fabiola Beatriz Rivaldi Montenegro +5 more
openalex +1 more source
Hyalohyphomycotic chronic rhinosinusitis caused by Microascus cirrosus in a cat
Abstract A 13‐year‐old, male, neutered, indoor‐only, domestic long‐haired cat was presented with an 8‐month history of sneezing and a 2‐month history of epistaxis. Computed tomography demonstrated an irregular contrast‐enhancing soft tissue opacity within both nasal cavities and osteolysis of surrounding bony structures.
Leonel Frutuoso +4 more
wiley +1 more source
THE LAST OF US: WHEN ASPERGILLUS NIGER STRIKES - A RARE CASE OF INVASIVE PULMONARY ASPERGILLOSIS IN AN UNLIKELY HOST [PDF]
R. C. Venkatesan +4 more
openalex +1 more source
ABSTRACT Objective The complement component 5 inhibitor therapies (C5ITs) eculizumab and ravulizumab are approved for the treatment of generalized myasthenia gravis (gMG). We evaluated the real‐world effectiveness and safety of eculizumab and ravulizumab in patients with gMG with or without prior intravenous immunoglobulin (IVIg) or plasma exchange ...
Akiyuki Uzawa +2 more
wiley +1 more source
Prolonged immunosuppressive therapy is a risk factor for invasive pulmonary aspergillosis. We report a case of a 79-yearold man who underwent immunosuppressive therapy with methylprednisolone and cyclosporine for an acute exacerbation of interstitial ...
Motoi Ugajin, Hisanori Kani
doaj +1 more source

